Effect of administration of sodium aurothiomalate on the virulence of yellow fever viruses in adult mice

C. A. Gibson, M. R. Wills, E. A. Gould, P. G. Sanders, Alan Barrett

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Administration of sodium aurothiomalate (SATM) to adult mice results in a reduction of their average survival time (AST) following intracerebral challenge with the wild-type strains, Asibi and French viscerotropic virus (FVV), of yellow fever (YF) virus. Most attenuated 17D YF vaccines, derived by passage of the wild-type Asibi strain in chick tissue, showed no reduction in AST following intracerebral challenge and administration of SATM. In contrast, challenge with the majority of live attenuated French neurotropic vaccines, derived by passage of FVV in mouse brain, still resulted in SATM reducing the AST of mice. SATM also changed some YF viruses from non-lethal to lethal following intraperitoneal challenge and negated the ability of a monoclonal antibody to elicit passive protection of mice challenged intracerebrally with YF virus.

Original languageEnglish (US)
Pages (from-to)590-594
Number of pages5
JournalVaccine
Volume8
Issue number6
DOIs
StatePublished - 1990
Externally publishedYes

Fingerprint

Yellow fever virus
Gold Sodium Thiomalate
Virulence
virulence
sodium
mice
Yellow Fever Vaccine
vaccines
Viruses
viruses
monoclonal antibodies
Vaccines
chicks
Monoclonal Antibodies
brain
Brain

Keywords

  • neurovirulence
  • sodium aurothiomalate
  • Yellow fever

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Effect of administration of sodium aurothiomalate on the virulence of yellow fever viruses in adult mice. / Gibson, C. A.; Wills, M. R.; Gould, E. A.; Sanders, P. G.; Barrett, Alan.

In: Vaccine, Vol. 8, No. 6, 1990, p. 590-594.

Research output: Contribution to journalArticle

Gibson, C. A. ; Wills, M. R. ; Gould, E. A. ; Sanders, P. G. ; Barrett, Alan. / Effect of administration of sodium aurothiomalate on the virulence of yellow fever viruses in adult mice. In: Vaccine. 1990 ; Vol. 8, No. 6. pp. 590-594.
@article{5c0421fce5e64c3e8b674c079d862407,
title = "Effect of administration of sodium aurothiomalate on the virulence of yellow fever viruses in adult mice",
abstract = "Administration of sodium aurothiomalate (SATM) to adult mice results in a reduction of their average survival time (AST) following intracerebral challenge with the wild-type strains, Asibi and French viscerotropic virus (FVV), of yellow fever (YF) virus. Most attenuated 17D YF vaccines, derived by passage of the wild-type Asibi strain in chick tissue, showed no reduction in AST following intracerebral challenge and administration of SATM. In contrast, challenge with the majority of live attenuated French neurotropic vaccines, derived by passage of FVV in mouse brain, still resulted in SATM reducing the AST of mice. SATM also changed some YF viruses from non-lethal to lethal following intraperitoneal challenge and negated the ability of a monoclonal antibody to elicit passive protection of mice challenged intracerebrally with YF virus.",
keywords = "neurovirulence, sodium aurothiomalate, Yellow fever",
author = "Gibson, {C. A.} and Wills, {M. R.} and Gould, {E. A.} and Sanders, {P. G.} and Alan Barrett",
year = "1990",
doi = "10.1016/0264-410X(90)90015-E",
language = "English (US)",
volume = "8",
pages = "590--594",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "6",

}

TY - JOUR

T1 - Effect of administration of sodium aurothiomalate on the virulence of yellow fever viruses in adult mice

AU - Gibson, C. A.

AU - Wills, M. R.

AU - Gould, E. A.

AU - Sanders, P. G.

AU - Barrett, Alan

PY - 1990

Y1 - 1990

N2 - Administration of sodium aurothiomalate (SATM) to adult mice results in a reduction of their average survival time (AST) following intracerebral challenge with the wild-type strains, Asibi and French viscerotropic virus (FVV), of yellow fever (YF) virus. Most attenuated 17D YF vaccines, derived by passage of the wild-type Asibi strain in chick tissue, showed no reduction in AST following intracerebral challenge and administration of SATM. In contrast, challenge with the majority of live attenuated French neurotropic vaccines, derived by passage of FVV in mouse brain, still resulted in SATM reducing the AST of mice. SATM also changed some YF viruses from non-lethal to lethal following intraperitoneal challenge and negated the ability of a monoclonal antibody to elicit passive protection of mice challenged intracerebrally with YF virus.

AB - Administration of sodium aurothiomalate (SATM) to adult mice results in a reduction of their average survival time (AST) following intracerebral challenge with the wild-type strains, Asibi and French viscerotropic virus (FVV), of yellow fever (YF) virus. Most attenuated 17D YF vaccines, derived by passage of the wild-type Asibi strain in chick tissue, showed no reduction in AST following intracerebral challenge and administration of SATM. In contrast, challenge with the majority of live attenuated French neurotropic vaccines, derived by passage of FVV in mouse brain, still resulted in SATM reducing the AST of mice. SATM also changed some YF viruses from non-lethal to lethal following intraperitoneal challenge and negated the ability of a monoclonal antibody to elicit passive protection of mice challenged intracerebrally with YF virus.

KW - neurovirulence

KW - sodium aurothiomalate

KW - Yellow fever

UR - http://www.scopus.com/inward/record.url?scp=0025690435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025690435&partnerID=8YFLogxK

U2 - 10.1016/0264-410X(90)90015-E

DO - 10.1016/0264-410X(90)90015-E

M3 - Article

VL - 8

SP - 590

EP - 594

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 6

ER -